How Trump’s approach to regulating AI in health care could diverge from Biden’s
A lot has happened with artificial intelligence since President-elect Donald Trump was last in the White House. Nudged into action by the advent of
Related Articles
Nurse suspended after patient baby claim wins dismissal case against NHS trust
Jessica Thorpe, who won an employment tribunal, says the past four years had been “a torture”.
Increased psoriasis risk found in cancer patients treated with immune checkpoint inhibitors
Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients with cancer undergoing immune checkpoint inhibitor (ICI)…
Baxter cuts annual profit forecast on hurricane impact
Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in…
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Highlights
Patients with diabetes and severe COVID-19 who were treated with dexamethasone had slower time to clinical recovery than propensity-matched patients who didn’t get dexamethasone, and…
Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns | CNN
Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and…
Recipe: Salmon Marsala
You read the title right. We’re switching out the chicken for fish to get all of your omega-3s.
Distinctive physiology of molecularly identified medium spiny neurons in the macaque putamen
Our study compares medium spiny neurons (MSNs) in macaque putamen tissue and mouse tissue using Patch-seq; this allows the comparison of electrophysiological, morphological, and transcriptomic…
The evolution of the understanding of obesity over the last 100 years
International Journal of Obesity – The evolution of the understanding of obesity over the last 100 years
Incretin-Based Therapies and Lifestyle Interventions: The Evolving Role of Registered Dietitian Nutritionists in Obesity Care
The emergence of incretin-based therapies, specifically glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and glucose-dependent insulinotropic polypeptide (GIP), as a new class of obesity medications, is…